Search
Standard BioTools Inc
LABAdd to Watchlist
0.606USD
-0.030-4.72%
Close 10-23 16:00（ET）
237.90MMarket Cap
3.03P/E TTM
After-hours 17:28 (ET)0.617USD+0.012+1.98%
After-hours 17:28 (ET)Standard BioTools Inc (LAB) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Standard BioTools Inc in the past month.
Hold
0 Strong Buy
0 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
1.350USD+114.63%
LAB Analyst Recommendation Trends
In the current month, LAB has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. LAB average Analyst price target in the last month is 1.350.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
1
1
1
1
1
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
2
2
2
3
3
3
LAB Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
14
9
1
0
35
Boston Scientific Corp
BSX
9
17
8
0
0
34
Thermo Fisher Scientific Inc
TMO
11
16
4
0
0
31
Edwards Lifesciences Corp
EW
10
15
6
0
0
31
Veeva Systems Inc
VEEV
8
14
7
1
0
30
Danaher Corp
DHR
11
13
3
0
0
27
Waters Corp
WAT
8
10
8
0
0
26
Agilent Technologies Inc
A
6
10
7
0
0
23
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Resmed Inc
RMD
3
8
10
1
1
23
Financial Forecasting
Based on analysts' estimates, LAB EPS is projected to reach -0.020 in FY2026Q3, following reported EPS of -0.068 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.07
-0.05
-0.01
-0.02
-0.02
Actual
0.05
0.33
-0.07
--
--
Surprise
+171.53%
+801.35%
-426.62%
--
--
FAQs
What is Standard BioTools Inc's expected revenue for the next quarter?
Standard BioTools Inc's expected revenue is 18.80M.
What is Standard BioTools Inc's price target?
Analysts forecast that Standard BioTools Inc's price target is USD 1.35, with the highest forecast at USD 1.35 and the lowest forecast at USD 1.35.
How have Standard BioTools IncLAB's recent earnings per share performed?
The market expectation was USD -0.07, while Standard BioTools IncLAB's earnings per share (EPS) for the previous quarter was USD 0.33. EPS for the next quarter is expected at USD -0.02.
What is the analyst rating for Standard BioTools Inc?
Based on the ratings of Standard BioTools Inc's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.